Betamethasone valerate

戊酸倍他米松

Report date: 2022/04/20 09:22:17
NME

Base Information

Drug NameBetamethasone valerate
Drug Alias NameLuxiqBeta-ValRinderon-VCelestoderm
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsHypersensitivityAutoimmune DiseasesPemphigus +[23] 
Global Approved IndicationsHypersensitivityAutoimmune DiseasesPemphigus +[20] 
Approved Indications in ChinaHypersensitivityAutoimmune DiseasesDermatitis, Allergic Contact +[7] 
Original Approved Country/TerritoryCanada
Original Approved Date1965/12/31
Country/TerritoryCanadaUnited StatesSweden +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpZiauddin Medical University Usa IncTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesPharmobedient Consulting LLCSchering AgAco Hud Nordic Ab
Active IndicationsHypersensitivityAutoimmune DiseasesPemphigus +[20] 
Inactive IndicationsDermatitisSkin DiseasesDermatitis, Atopic

Other Information

ATC CodeA07EA04C05AA05D07AC01 +[11] 
Related LinksWikipediaDrugBankKEGG